This trial is testing a patient guide to help make decisions about breast cancer treatment.
- Breast Cancer
3 Primary · 2 Secondary · Reporting Duration: up to 120-days following surgery
Awards & Highlights
1 Treatment Group
Breast cancer decision aid
1 of 1
40 Total Participants · 1 Treatment Group
Primary Treatment: Breast cancer decision aid · No Placebo Group · N/A
Who is running the clinical trial?
Age 65+ · Female Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
- Schonberg, Mara A., Rachel A. Freedman, Abram R. Recht, Alicia R. Jacobson, Gianna M. Aliberti, Maria Karamourtopoulos, Faina Nakhlis, et al.. 2019. “Developing a Patient Decision Aid for Women Aged 70 and Older with Early Stage, Estrogen Receptor Positive, HER2 Negative, Breast Cancer”. Journal of Geriatric Oncology. Elsevier BV. doi:10.1016/j.jgo.2019.05.004.
- 2022. "Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05140252.
Frequently Asked Questions
Are there any vacant positions available to participate in this experiment?
"Affirmative. Clinicaltrials.gov registers that this research project, which was originally published on May 12th 2022, is now actively recruiting individuals for participation. The trial is aiming to enroll 40 patients at a single site." - Anonymous Online Contributor
How many individuals are participating in this clinical trial?
"Affirmative. Clinicaltrials.gov contains evidence that this clinical research is presently recruiting participants, with an initial posting on May 12th 2022 and a most recent update occurring August 31st of the same year. 40 volunteers are being sought from 1 medical centre for participation in the trial." - Anonymous Online Contributor